Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation
- PMID: 26307013
- PMCID: PMC5734625
- DOI: 10.1126/scisignal.aaa3206
Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation
Abstract
Inflammatory critical illness is a syndrome that is characterized by acute inflammation and organ injury, and it is triggered by infections and noninfectious tissue injury, both of which activate innate immune receptors and pathways. Although reports suggest an anti-inflammatory role for the mitogen-activated protein kinase (MAPK) extracellular signal-regulated kinase 5 (ERK5), we previously found that ERK5 mediates proinflammatory responses in primary human cells in response to stimulation of Toll-like receptor 2 (TLR2). We inhibited the kinase activities and reduced the abundances of ERK5 and MEK5, a MAPK kinase directly upstream of ERK5, in primary human vascular endothelial cells and monocytes, and found that ERK5 promoted inflammation induced by a broad range of microbial TLR agonists and by the proinflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). Furthermore, we found that inhibitors of MEK5 or ERK5 reduced the plasma concentrations of proinflammatory cytokines in mice challenged with TLR ligands or heat-killed Staphylococcus aureus, as well as in mice that underwent sterile lung ischemia-reperfusion injury. Finally, we found that inhibition of ERK5 protected endotoxemic mice from death. Together, our studies support a proinflammatory role for ERK5 in primary human endothelial cells and monocytes, and suggest that ERK5 is a potential therapeutic target in diverse disorders that cause inflammatory critical illness.
Copyright © 2015, American Association for the Advancement of Science.
Conflict of interest statement
Figures








Similar articles
-
SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype.J Leukoc Biol. 2016 May;99(5):711-21. doi: 10.1189/jlb.2A0715-307R. Epub 2015 Nov 20. J Leukoc Biol. 2016. PMID: 26590148
-
Tumor necrosis factor-α and interleukin-1β expression pathway induced by Streptococcus mutans in macrophage cell line RAW 264.7.Mol Oral Microbiol. 2012 Jun;27(3):149-59. doi: 10.1111/j.2041-1014.2012.00639.x. Epub 2012 Feb 9. Mol Oral Microbiol. 2012. PMID: 22520385
-
ERK5 protein promotes, whereas MEK1 protein differentially regulates, the Toll-like receptor 2 protein-dependent activation of human endothelial cells and monocytes.J Biol Chem. 2012 Aug 3;287(32):26478-94. doi: 10.1074/jbc.M112.359489. Epub 2012 Jun 15. J Biol Chem. 2012. PMID: 22707717 Free PMC article.
-
Decoding cell death signals in liver inflammation.J Hepatol. 2013 Sep;59(3):583-94. doi: 10.1016/j.jhep.2013.03.033. Epub 2013 Apr 6. J Hepatol. 2013. PMID: 23567086 Review.
-
ERK5 Mediated Signalling in Diabetic Retinopathy.Med Hypothesis Discov Innov Ophthalmol. 2015 Spring;4(1):17-26. Med Hypothesis Discov Innov Ophthalmol. 2015. PMID: 25861671 Free PMC article. Review.
Cited by
-
MEK5/ERK5 activation regulates colon cancer stem-like cell properties.Cell Death Discov. 2019 Feb 11;5:68. doi: 10.1038/s41420-019-0150-1. eCollection 2019. Cell Death Discov. 2019. PMID: 30774996 Free PMC article.
-
Developing A Baseline Metabolomic Signature Associated with COVID-19 Severity: Insights from Prospective Trials Encompassing 13 U.S. Centers.Metabolites. 2023 Oct 24;13(11):1107. doi: 10.3390/metabo13111107. Metabolites. 2023. PMID: 37999202 Free PMC article.
-
Bone and Extracellular Signal-Related Kinase 5 (ERK5).Biomolecules. 2024 May 4;14(5):556. doi: 10.3390/biom14050556. Biomolecules. 2024. PMID: 38785963 Free PMC article. Review.
-
Single Cell Transcriptomics Implicate Novel Monocyte and T Cell Immune Dysregulation in Sarcoidosis.Front Immunol. 2020 Dec 8;11:567342. doi: 10.3389/fimmu.2020.567342. eCollection 2020. Front Immunol. 2020. PMID: 33363531 Free PMC article.
-
Taoren Honghua Drug Attenuates Atherosclerosis and Plays an Anti-Inflammatory Role in ApoE Knock-Out Mice and RAW264.7 Cells.Front Pharmacol. 2020 Jul 17;11:1070. doi: 10.3389/fphar.2020.01070. eCollection 2020. Front Pharmacol. 2020. PMID: 32765273 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous